3oz

Vasoburn 3oz Pump Bottle

Vasoburn 3oz Pump Bottle

Introducing MPA Vasoburn

MPA VasoBurn is a topical skin gel that glides on smoothly, and dries rapidly. The ingredients in MPA VasoBurn may support the appearance of tighter , firmer, and thinner skin texture for an overall leaner appearance

A Topical Capsaicin Skin Gel

  • Clean Gel application
  • Rapidly dries
  • Pleasant scent of cinnamony

#Vasoburn

MPA VASOBURNTM

MPA VasoBurn is a topical skin gel that glides on smoothly, and dries rapidly. The ingredients in MPA VasoBurn may support the appearance of tighter , firmer, and thinner skin texture for an overall leaner appearance. This product is ideal for use in combination with/during your caloric deprivation periods - i.e. rigorous dieting, low carbohydrate nutrition protocols, that support a low insulin environment. *Remember to always consult with your doctor before beginning any diet or exercise program. 

  • Clean gel application
  • Rapidly dries
  • Pleasant scent of cinnamon
  • Ideal for use in combination with/during your low carbohydrate/caloric deficient periods

*Please refer to the references below in regard to the ingredients in MPA VasoBurn for what the ingredients have been suggested to do*

Application for MPA VasoBurnTM

The best places to apply MPA VasoBurn are --- abdominals, glutes, inner thighs, chest, and of course … the lower back.

Apply MPA VasoBurn after showering -- washing away dead skin cells from the body --ensuring maximum coverage.

A finely trimmed or shaved body may also enhance the application of ingredients by negating the occurrence of body hair that can make application difficult.

-Matt Porter

Product Creator & Nutrition Coach

Ingredients:

Water (Aqua/Eua), Ethyl Alcohol (organic), Dimethyl Isosorbide, Ethoxydiglycol, 3-Aminopropanoic Acid, Yohimbine Hydrochloride, Triethanolamine, Theophylline, Zingiber Officinale (Ginger) Root Extract, Carbomer, Raspberry Ketone, Benzyl Nicotinate, Trans-Cinnamaldehyde oil, Tetrahydropiperine*, N-Vanillylnonanamide.

References

  1. C Morimoto, et al. Life Sci, May 27, 2005; 77(2): 194-204
  1. Frank et al. Obes Res. 1995;3 (Suppl 4): 561S-568S
  2.  Caruso MK, et al Diabetes Obes Metab. 2007 May;9(3):300-3.
  1. Zhao X, et al. Int J Pharm. 2006 Dec 11;327(1-2):58-64. Epub 2006 Jul 21.
  1. GD Lundberg Medscape J Med, Jan 2008; 10(2): 43.
  2. Kobayashi,Y. et al. Planta Med., 67, 628–633.(2001)

  3. P Arner, et al.J. Lipid Res., Oct 1993; 34: 1737.